The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis (Q59689568)
Jump to navigation
Jump to search
scholarly article by G A Ellard et al published June 1986 in The American Review of Respiratory Disease
Language | Label | Description | Also known as |
---|---|---|---|
English | The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis |
scholarly article by G A Ellard et al published June 1986 in The American Review of Respiratory Disease |
Statements
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis (English)
0 references
June 1986
0 references
133
0 references
6
0 references
1076-80
0 references